A Comparative Study to evaluate the analgesic efficacy of addition of dexmedetomidine as an adjuvant to 0.375% Ropivacaine in adductor canal block for knee Surgeries for post operative analgesia

A Comparative Randomised Study to evaluate the analgesic efficacy of addition of dexmedetomidine as an adjuvant to 0.375% Ropivacaine in adductor canal block for knee Surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054502

Enrollment

Registered

2023-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S820- Fracture of patella Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Comparative study to evaluate the analgesic efficacy of addition of dexmeditomidine as an adjuvant with 0.375% Ropivacaine in adductor canal block for knee surgeries: Adductor canal blo

0 â?? No pain & 10 â?? Worst imaginable pain. The pain will be assessed at 2 hr,4hr,six, twelve, and twenty fours post-surgery. Rescue analgesia with intravenous tramadol 2mg/kg will provided if VAS i

Eligibility

Inclusion criteria

Inclusion criteria: All patients who will be undergoing surgeries around knee that can be done under spinal anesthesia ASA1 to ASA 3 Age between 18-80yr

Exclusion criteria

Exclusion criteria: Patients refusal to ACB Patients undergoing bilateral surgery Patients with neurological disorders Patients with musculoskeletal disorder Need for adjuvant blocks (Popliteal) Allergy to study drugs Infection in area in the surgical area Coagulopathy Relative contraindications

Design outcomes

Primary

Measure	Time frame
Duration of post operative analgesiaTimepoint: Duration of post operative analgesia after 2hours, 4hours, 8hours, 12hours, 24hours	—

Secondary

Measure	Time frame
Total analgesia consumption in first 24hr Time to Ambulation Sedation Score Hemodynamics Overall patient satisfaction Any other adverse eventsTimepoint: 4hours,6hours,12hours,24hours	—

Countries

India

Contacts

Public ContactDr Anand

Vijaynagara Institute of medical sciences, Ballari

nkiranchand@yahoo.com9845857056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026